Cargando…
Galectin-3: a possible complementary marker to the PSA blood test
The prostate-specific antigen (PSA) test has served as a blood marker of prostate cancer (PCa), and for monitoring recurrence/metastasis in patients after therapeutic intervention. However, the applicability/reliability of the PSA test was recently questioned as it is not without challenges, in part...
Autores principales: | Balan, Vitaly, Wang, Yi, Nangia-Makker, Pratima, Kho, Dhonghyo, Bajaj, Madhuri, Smith, Daryn, Heilbrun, Lance, Raz, Avraham, Heath, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720602/ https://www.ncbi.nlm.nih.gov/pubmed/23625538 |
Ejemplares similares
-
Galectin-3 regulates p21 stability in human prostate cancer cells
por: Wang, Yi, et al.
Publicado: (2012) -
Galectins as Cancer Biomarkers
por: Balan, Vitaly, et al.
Publicado: (2010) -
Regulation of Tumor Progression by Extracellular Galectin-3
por: Nangia-Makker, Pratima, et al.
Publicado: (2008) -
Positive associations between galectin-3 and PSA levels in prostate cancer patients: a prospective clinical study-I
por: Nakajima, Kosei, et al.
Publicado: (2016) -
Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseases
por: Nangia-Makker, Pratima, et al.
Publicado: (2022)